← Back to Clinical Trials
Recruiting NCT06473454

NCT06473454 Patients With Irritable Bowel Syndrome and Physiotherapy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06473454
Status Recruiting
Phase
Sponsor Istanbul Saglik Bilimleri University
Condition Irritable Bowel Syndrome
Study Type INTERVENTIONAL
Enrollment 72 participants
Start Date 2024-07-20
Primary Completion 2024-12-15

Trial Parameters

Condition Irritable Bowel Syndrome
Sponsor Istanbul Saglik Bilimleri University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 72
Sex ALL
Min Age 18 Years
Max Age 65 Years
Start Date 2024-07-20
Completion 2024-12-15
Interventions
aerobic exercise and basic body awareness therapy ( exercise)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The research will be planned on 72 individuals between the ages of 18-65 who were diagnosed with irritable bowel syndrome at Istanbul Medipol University Çamlıca SUAM Gastroenterology Polyclinic. Patients will be divided into 3 groups; High-intensity interval training and a disease-specific nutrition program for the first group, and a disease-specific nutrition program for the second group; Basic Body Awareness Therapy (BBAT) and a disease-specific nutrition program will be given, while the control group will be given only a disease-specific nutrition program. Evaluations will be made immediately before and after treatment. The first experimental group will be asked to walk with high-intensity interval training, which the investigators plan for 30 minutes, 4 days a week for 8 weeks. TBFT will be applied to the second experimental group every day of the week. The application will be done face to face one day a week, and the patient will be asked to do it himself on the other days, and the sessions will last approximately 30 minutes. In addition, all patients will be asked to follow the nutrition program determined by the dietician. Participants' sociodemographic information, IBS disease type and medications used will be recorded. In order to collect data for both the intervention groups and the control group immediately before and after the study; 6 Minute Walk Test (6MWT), posture analysis, muscle shortness test for large muscle groups in the lower and upper extremities, International Physical Activity Questionnaire Short Form (IPAQ-SF), Diet Compliance Questionnaire Form, Bristol Stool Scale Form, Gastrointestinal Symptom Assessment Scale (GSDS). ), Pittsburgh Sleep Quality Index (PSQI), IBS Quality of Life Scale (IBS-QOL), Morningness-Eveningness Questionnaire (SAA), Psychological Well-Being Scale (PIOS) and Body Awareness Questionnaire (VFA) will be used.

Eligibility Criteria

inclusion criterias 1\. Being between the ages of 18-65 2. Compliance with Rome IV criteria 3. Declaring that you wish to participate in the study with written consent exclusion criterias 1. Voluntary refusal to participate in the study 2. Having a psychiatric illness 3. Not having any orthopedic, neurological or cardiopulmonary disease that would constitute a contraindication for the protocols to be applied. 4. Do not pose any risk of injury while working in line with posture analysis. 5. In case the limitations in muscle shortness tests prevent the study 6. Using laxatives regularly 7. Being diagnosed with diabetes or a metabolic disease that will affect the gastrointestinal system 8. No history of Inflammatory Bowel Disease (IBD), colon cancer or colon resection 9. Using antibiotics and probiotics in the last 3 months 10. Using anticholinergic, opiate or morphine-type drugs that will affect intestinal motility 11. Getting diagnosed with celiac disease

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology